Kiora Pharmaceuticals
KPRX
KPRX
23 hedge funds and large institutions have $7.87M invested in Kiora Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
Holders
23
Holding in Top 10
–
Calls
$4.33M
Puts
–
Top Buyers
| 1 | +$1.62M | |
| 2 | +$1.62M | |
| 3 | +$1.55M | |
| 4 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$1.34M |
| 5 |
VCIM
Velan Capital Investment Management
Alpharetta,
Georgia
|
+$777K |
Top Sellers
| 1 | -$49.1K | |
| 2 | -$12.5K | |
| 3 | -$1.47K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$1.15K |
| 5 |
Morgan Stanley
New York
|
-$6 |